| Bid Price | 581.00p | High Price | 605.00p |
|---|
| Ask Price | 583.00p | Low Price | 578.00p |
|---|
| Open Price | 605.00p | Spread | 0.34% |
|---|
| Prev Close | 600.00p | Volume | 344,453 |
|---|
Oxford Biomedica PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 11, 2025 | 599.00 | 605.00 | 594.00 | 600.00 | 146,333 |
| Sep 10, 2025 | 598.00 | 613.15 | 591.00 | 602.00 | 347,483 |
| Sep 9, 2025 | 595.00 | 597.00 | 570.00 | 593.00 | 219,460 |
| Sep 8, 2025 | 592.00 | 600.00 | 588.00 | 590.00 | 255,665 |
Oxford Biomedica PLC Information
| Name | Oxford Biomedica PLC | Index | FTSE All Share |
|---|
| ISIN | GB00BDFBVT43 | Epic | OXB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSMM |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 3,000 | Trading Status | Closed |
|---|
| Shares in Issue | 120.18 m | Prev Close | 600.00p |
|---|
| PE Ratio | 20.618557 | Market Cap | £694.65 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.11 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.044444 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.283809 | Quick Ratio | 1.762024 |
|---|
Oxford Biomedica PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 22/08/25 | SELL | Dame Davies | NED | 4,563 @ £5.00 | £22,833.00 |
| 22/08/25 | BUY | Dame Davies | NED | 4,563 @ £4.36 | £19,895.00 |
| 15/08/25 | BUY | Roch Doliveux | CH | 67,000 @ £4.50 | £301,333.00 |
| 17/06/25 | BUY | Heather Preston | NED | 11,389 @ £3.24 | £36,900.00 |
| 16/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 14/11/23 | BUY | Michael Hayden | RES | 10,000 @ £1.93 | £19,281.00 |
| 11/10/23 | BUY | Namrata Patel | NED | 1,670 @ £2.99 | £4,993.00 |
| 27/09/23 | BUY | Michael Hayden | RES | 12,000 @ £2.94 | £35,220.00 |
| 26/09/23 | BUY | Leone Patterson | RES | 6,598 @ £2.91 | £19,167.00 |
| 26/09/23 | BUY | Dame Davies | NED | 1,000 @ £2.91 | £2,910.00 |
Oxford Biomedica PLC News
